Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1286-1292

  Nishikawa, Jun ^a,b   Imai, Shosuke ^b   Oda, Takanori ^b   Kojima, Toshichika ^c   Okita, Kiwamu ^a   Takada, Kenzo ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFECTIOUS MONONUCLEOSIS; MOLECULAR CLONING; NASOPHARYNX CANCER; PHENOTYPE; PLASMID; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH PARIETAL CELL; VIRUS INFECTION;

EID: 0032949142     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1286-1292.1999     Document Type: Article

References (47)

1. Akiyama, S., H. Amo, T. Watanabe, M. Matsuyama, J. Sakamoto, M. Imaizumi, H. Icbihashi, T. Kondo, and H. Takagi. 1988. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn. J. Surg. 18:438-446.
2. Baker, S. J., S. Markowitz, and E. R. Fearson. 1990. Suppression of human colorectal cell growth hy wild-type p53. Science 249:912-915.
3. Clarke, P. A., M. Schwemmle, J. Schickinger, K. Hilse, and M. J. Clemens. 1992. Binding of Epstein-Barr virus small RNA EBER-I to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19:243-248.
4. Craanen, M. E., P. Blok, W. Dekker, G. J. Offerhaus, and G. N. Tygat. 1995. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 36: 848-852.
5. Dawson, C. W., A. B. Rickinson, and L. S. Young. 1990. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780.
6. Dimery, I. W., J. S. Lee, M. Blick, G. Pearson, G. Spitzer, and W. K. Hong. 1988. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 61:2475-2480.
7. Fahraeus, R., L. Rymo, J. S. Rhim, and G. Klein. 1990. Morphological transformation of human keratinocytes expressing the LMP gene of EpsteinBarr virus. Nature 345:447-449.
8. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653-8659.
9. Gulley, M. L., D. R. Pulitzer, P. A. Eagan, and B. G. Schneider. 1996. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of b0l-2 expression and p53 accumulation. Hum. Pathol. 27:20-27.
10. Gulley, M. L., M. P. Burton, D. C. Allred, J. M. Nicholls, M. B. Amin, J. Y. Ro, and B. G. Schneider. 1998. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum. Pathol. 29:252-259.
11. Harn, H. J., L. I. Ho, W. H. Chung, J. J. Lin, H. S. Lee, and W. H. Lee. 1995. Epstein-Barr virus-associated typical gastric carcinoma detected by in situ hybridization and polymerase chain reaction. J. Clin. Gastroenterol. 20:253-254.
12. Hurley, E. A., S. Agger, J. A. MacNeil, J. B. Laurence, A. Calender, G. Lenoir, and D. A. Thorley-Lawson. 1991. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J. Virol. 65:1245-1254.
13. Imai, S., S. Koizumi, M. Sugiura, M. Tokunaga, Y. Uemura, N. Yamamoto, S. Tanaka, E. Sato, and T. Osato. 1994. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA 91:9131-9135.
14. lmai, S., J. Nishikawa, and K. Takada. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371-4378.
15. Komano, J., M. Sugiura, and K. Takada. 1998. Epstein-Barr virus contributes to the malignant phenotype and apotosis resistance in Burkitt's lymphoma cell line Akata. J. Virol. 72:9150-9156.
16. Koromilas, A. E., S. Roy, G. N. Barber, M. G. Kalze, and N. Sonenberg. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689.
17. Kuerbitz, S. J., B. S. Plunkelt, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle check point determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
18. Leoncini, L., C. Vindigni, T. Megha, I. Funro, L. Pacenti, M. Musaro, A. Renieri, M. Seri, J. Anagnostoponlos, and P. Tosi. 1993. Epstein-Barr virus and gastric cancer, data and unanswered questions. Int. J. Cancer 53:898-901.
19. Matsuo, T., M. Heller, L. Petti, E. O'Shiro, and E. Kieff. 1984. Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226:1322-1325.
20. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
21. Miller, W. E., H. S. Earp, and N. Raab-Traub. 1995. The Epslein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:4390-4398.
22. Nonkwelo, C., J. Skinner, A. Bell, A. Rickinson, and J. Sample. 1996. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:623-627.
23. Ochiai, A., Y. Yamauchi, and S. Hirohashi. 1996. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int. J. Cancer 69:28-33.
24. Panousis, C. G., and D. T. Rowe. 1997. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J. Virol. 71:4752-4760.
25. Pearson, G. R., B. Woman, B. Chase, T. Sculley. M. Hummel, and E. Kieff. 1983. Identification of polypeptide components of the Epstein-Barr virus early antigen complex by using monoclonal antibodies. J. Virol. 47:193-201.
26. Raab-Traub, N., and K. Flynn. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889.
27. Rickinson, A. B., and E. Kieff 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
28. Rowe, M., A. L. Lear, D. Croom-Carter, A. H. Davis, and A. B. Rickinson. 1992. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 66:122-131.
29. Saw, D., D. H. Lau, J. H. C. Ho, J. K. C. Chan, and C. S. Ng. 1986. Malignant lymphoepithelial lesion of the salivary gland. Hum. Pathol. 17:914-923.
30. Selves, J., F. Bibeau, P. Brousset, F. Meggetto, C. Mazerolles, J. J. Voigt, B. Pradere, P. Chiotasso, and G. Delsol. 1996. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology 28:121-127.
31. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-I gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565-10569.
32. Shiao, Y. H., M. Rugge, P. Correa, H. P. Lehmann, and W. D. Scheer. 1994. p53 alteration in gastric precancerous lesions. Am. J. Pathol. 144:511-517.
33. Shibata, D., M. Tokunaga, Y. Uemura, E. Sato, S. Tanaka, and L. M. Weiss. 1991. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration Lymphoepithelioma-like carcinoma. Am. J. Pathol. 139:469-474.
34. Shibata, D., and L. M. Weiss. 1992. Epslein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 140:769-774.
35. Shimizu, N., H. Yushiyama, and K. Takada. 1996. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol. 70:7260-7263.
36. Shimizu, N., A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada. 1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenorypes of BL cells are dependent on EBV. J. Virol. 68:6069-6073.
37. Sugiura, M., S. Imai, M. Tokunaga, S. Koizumi, M. Uchizawa, K. Okamoto, and T. Osato. 1996. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br. J. Cancer 74:625-631.
38. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
39. Thorley-Lawson, D. A., and K. Geilinger. 1980. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc. Natl. Acad. Sci. USA 77:5307-5311.
40. Weiss, L. M., Y. Y. Chen, X. F. Liu, and D. Shibata. 1991. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am. J. Pathol. 139:1259-1265.
41. Wilson, J. B., W. Weinberg, R. Johnson, S. Yuspa, and A. J. Levine. 1990. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-1327.
42. Wilson, J. B., and A. J. Levine. 1992. The oncogenic potential of EpsteinBarr virus nuclear antigen 1 in transgenic mice. Curr. Top. Microbiol. Immunol. 182:375-384.
43. Yoshiyama, H., N. Shimizu, and K. Takada. 1995. Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent viral expression. EMBOJ. 14:3706-3711.
44. Yoshiyama, H., S. Imai, N. Shimizu, and K. Takada. 1997. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 71:5688-5691.
45. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 353:345-347.
46. Young, L., C. Alfteri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kief, and J. I. Cohen. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
47. Young, L. S., C. W. Dawson, D. Clark, H. Rupani, P. Busson, T. Tursz, A. Johnson, and A. B. Rickinson. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69:1051-1065.